| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT07552181 | Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in… | TNBC - Triple-Negative Breast Cancer | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05318469 | Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic… | Anatomic Stage IV Breast Cancer AJCC v8 | Recruiting |